End-payors seek final ok for AstraZeneca, Handa settlement in US antitrust case over Seroquel XR
MLex Summary: End-payor plaintiffs asked a US federal judge for final approval to their $5.47 million settlement with AstraZeneca and Handa Pharmaceuticals to resolve US antitrust claims over the drug Seroquel...To view the full article, register now.
Already a subscriber? Click here to view full article